Unprecedented silver resistance in clinically isolated Enterobacteriaceae: Major implications for burn and wound management

Antimicrobial Agents and Chemotherapy

Volumn 59, Issue 8, 2015, Pages 4734-4741

  Finley, Phillip J ^a   Norton, Rhy ^b   Austin, Cindy ^a   Mitchell, Amber ^a   Zank, Sara ^a   Durham, Paul ^b  

^a Mercy Hospital   (United States)

^b Center for Biomedical and Life Sciences   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; OUTER MEMBRANE PROTEIN; SILVER DERIVATIVE; SILVER NANOPARTICLE; ANTIINFECTIVE AGENT; SILVER;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERIUM ISOLATE; BURN; CANDIDA; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DNA SEQUENCE; ENTEROBACTER; ENTEROBACTER CLOACAE; ENTEROBACTERIACEAE; ENTEROCOCCUS; ESCHERICHIA; ESCHERICHIA COLI; GENE LOCATION; INHIBITION ZONE; KLEBSIELLA; KLEBSIELLA PNEUMONIAE; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR INTERACTION; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS; SCANNING ELECTRON MICROSCOPY; SEQUENCE ANALYSIS; SILVER DRESSING; STAPHYLOCOCCUS; WOUND CARE; BANDAGE; BURNS; DRUG EFFECTS; ENTEROBACTERIACEAE INFECTIONS; HUMAN; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; PROCEDURES; WOUND INFECTION;

ANTI-BACTERIAL AGENTS; BANDAGES; BURNS; DRUG RESISTANCE, BACTERIAL; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; HUMANS; MICROBIAL SENSITIVITY TESTS; SILVER; WOUND INFECTION;

EID: 84939865014     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00026-15     Document Type: Article

References (39)

1. Lansdown AB. 2002. Its antibacterial properties and mechanism of action. J Wound Care 11:125-130. http://dx.doi.org/10.12968/jowc.2002.11.4.26389.
2. Lansdown AB. 2002. Silver 2: toxicity in mammals and how its products aid wound repair. J Wound Care 11:173-177. http://dx.doi.org/10.12968/jowc.2002.11.5.26398.
3. Dowsett C. 2004. The use of silver-based dressings in wound care. Nurs Stand 19:56-66. http://dx.doi.org/10.7748/ns2004.10.19.7.56.c3736.
4. Markowitz SM, Smith SM, Williams DS. 1983. Retrospective analysis of plasmid patterns in a study of burn unit outbreaks of infections due to Enterobacter cloacae. J Infect Dis 148:18-23. http://dx.doi.org/10.1093/infdis/148.1.18.
5. Klasen HJ. 2000. Historical review of the use of silver in the treatment of burns. I. Early uses. Burns 26:117-130. http://dx.doi.org/10.1016/S0305-4179(99)00108-4.
6. Klasen HJ. 2000. A historical review of the use of silver in the treatment of burns. II. Renewed interest for silver. Burns 26:131-138. http://dx.doi.org/10.1016/S0305-4179(99)00116-3.
7. Chopra I. 2007. The increasing use of silver-based products as antimicrobial agents: a useful development or a cause for concern? J Antimicrob Chemother 59:587-590. http://dx.doi.org/10.1093/jac/dkm006.
8. McHugh GL, Moellering RC, Hopkins CC, Swartz MN. 1975. Salmonella typhimurium resistance to silver nitrate, chloramphenicol, and ampicillin. Lancet i:235-240.
9. Gupta A, Matsui K, Lo JF, Silver S. 1999. Molecular basis for resistance to silver cations in Salmonella. Nat Med 5:183-188. http://dx.doi.org/10.1038/5545.
10. Gupta A, Phung LT, Taylor DE, Silver S. 2001. Diversity of silver resistance genes in IncH incompatibility group plasmids. Microbiology 147:393-402.
11. Belly RT, Kydd GC. 1982. Silver resistance in microorganisms. Dev Ind Microbiol 23:567-578.
12. Annear DI, Mee BJ, Bailey M. 1976. Instability and linkage of silver resistance, lactose fermentation, and colony structure in Enterobacter cloacae from burn wounds. J Clin Pathol 29:441-443. http://dx.doi.org/10.1136/jcp.29.5.441.
13. Carr HS, Rosenkranz HS. 1975. R factor in Enterobacter cloacae resistant to silver sulfadiazine. Chemotherapy 21:41-44. http://dx.doi.org/10.1159/000221842.
14. Hendry AT, Stewart IO. 1979. Silver-resistant Enterobacteriaceae from hospital patients. Can J Microbiol 25:915-921. http://dx.doi.org/10.1139/m79-136.
15. Grewal JS, Tiwari RP. 1990. Resistance to metal ions and antibiotics in Escherichia coli isolated from foodstuffs. J Med Microbiol 32:223-226. http://dx.doi.org/10.1099/00222615-32-4-223.
16. Baquero F. 2001. Low level antibacterial resistance: a gateway to clinical resistance. Drug Resist Updat 4:93-105. http://dx.doi.org/10.1054/drup.2001.0196.
17. Starodub ME, Trevors JT. 1989. Silver resistance in Escherichia coli. J Med Microbiol 29:101-110. http://dx.doi.org/10.1099/00222615-29-2-101.
18. Haefeli C, Franklin C, Hardy K. 1984. Plasmid-determined silver resistance in Pseudomonas stutzeri isolated from a silver mine. J Bacteriol 158:389-392.
19. Deshpande LM, Chopade BA. 1994. Plasmid mediated silver resistance in Acinetobacter baumannii. Biometals 7:49-56.
20. Choudhury P, Kumar R. 1998. Multidrug- and metal-resistant strains of Klebsiella pneumoniae isolated from Penaeus monodon of the coastal waters of deltaic Sundarban. Can J Microbiol 44:186-189. http://dx.doi.org/10.1139/w97-144.
21. Loh JV, Percival SL, Woods EJ. 2009. Silver resistance in MRSA isolated from wound and nasal sources in humans and animals. Int Wound J 6:32-38. http://dx.doi.org/10.1111/j.1742-481X.2008.00563.x.
22. Gilmour MW, Thomson NR, Sanders M, Parkhill J, Taylor DE. 2004. The complete nucleotide sequence of the resistance plasmid R478: defining the backbone components of incompatibility group H conjugative plasmids through comparative genomics. Plasmid 52:182-202. http://dx.doi.org/10.1016/j.plasmid.2004.06.006.
23. Johnson TJ, Wannemeuhler YM, Scaccianoce JA, Johnson SJ, Nolan LK. 2006. Complete DNA sequence, comparative genomics, and prevalence of an IncH12 plasmid occurring among extraintestinal pathogenic Escherichia coli isolates. Antimicrob Agents Chemother 50:3929-3933. http://dx.doi.org/10.1128/AAC.00569-06.
24. Randall CP, Gupta A, Jackson N, Busse D, O'Neil AJ. 2015. Silver resistance in Gram-negative bacteria: a dissection of endogenous and exogenous mechanisms. J Antimicrob Chemother 70:1037-1046. http://dx.doi.org/10.1093/jac/dku523.
25. Delmar JA, Su C, Yu EW. 2013. Structural mechanisms of heavy-metal extrusion by the Cus efflux system. Biometals 26:593-607. http://dx.doi.org/10.1007/s10534-013-9628-0.
26. Klaus T, Joerger R, Olsson E, Granqvist CG. 1999. Silver-based crystalline nanoparticles, microbially fabricated. Proc Natl Acad Sci U S A 96: 13611-13614. http://dx.doi.org/10.1073/pnas.96.24.13611.
27. Percival SL, Woods E, Nutekpor M. 2008. Prevalence of silver resistance in bacteria isolated from diabetic foot ulcers and efficacy of silver-containing wound dressings. Ostomy Wound Manage 54:30-40.
28. Woods EJ, Cochrane CA, Percival SL. 1999. Prevalence of silver resistance genes in bacteria isolated from human and horse wounds. Vet Microbiol 138:325-329.
29. ASTM. 2001. Standard E2149-01. Standard test method for determining antimicrobial activity of immobilized antimicrobial agents under dynamic contact conditions. ASTM International, West Conshohocken, PA.
30. Maher D, Taylor DE. 1993. Host range and transfer efficiency of incompatibility group HI plasmids. Can J Microbiol 39:581-587. http://dx.doi.org/10.1139/m93-084.
31. NDM-1-harbouring plasmid from Providencia rettgeri and an FII-type plasmid from Klebsiella pneumoniae identified in Canada. J Antimicrob Chemother 69:637-642. http://dx.doi.org/10.1093/jac/dkt445.
32. Sedlak RH, Hnilova M, Grosh C, Fong H, Baneyx F, Schwartz D, Sarikaya M. 2012. Engineered Escherichia coli silver-binding periplasmic protein that promotes silver tolerance. Appl Environ Microbiol 78:2289-2296. http://dx.doi.org/10.1128/AEM.06823-11.
33. Fu JK, Liu YY, Gu PY, Tang DL, Lin ZY, Yah BX, Wen SZ. 2000. Spectroscopic characterization on the biosorption and bioreduction of Ag(I) by Lactobacillus sp. AO9. Acta Phys Chim Sin 16:779-782. http://dx.doi.org/10.3866/PKU.WHXB20000904.
34. Law N, Ansari S, Livens FR, Renshaw JC, Lloyd JR. 2008. Formation of nanoscale elemental silver particles via enzymatic reduction by Geobacter sulfurreducens. Appl Environ Microbiol 74:7090-7093. http://dx.doi.org/10.1128/AEM.01069-08.
35. Leang C, Coppi MV, Lovley DR. 2003. OmcB, a c-type polyheme cytochrome, involved in Fe(III) reduction in Geobacter sulfurreducens. J Bacteriol 185:2096-2103. http://dx.doi.org/10.1128/JB.185.7.2096-2103.2003.
36. Wright JB, Lam K, Buret AG, Olson ME, Burrell RE. 2010. Early healing events in a porcine model of contaminated wounds: effects of nanocrystalline silver on matrix metalloproteinases, cell apoptosis, and healing. Wound Repair Regen 10:141-151. http://dx.doi.org/10.1046/j.1524-475X.2002.10308.x.
37. Bhol KC, Schechter PJ. 2005. Topical nanocrystalline silver cream suppresses inflammatory cytokines and induces apoptosis of inflammatory cells in a murine model of allergic contact dermatitis. Br J Dermatol 152:1235. http://dx.doi.org/10.1111/j.1365-2133.2005.06575.x.
38. Bhol KC, Alroy J, Schechter PJ. 2004. Anti-inflammatory effect of topical nanocrystalline silver cream on allergic contact dermatitis in a guinea pig model. Clin Exp Dermatol 29:282-287. http://dx.doi.org/10.1111/j.1365-2230.2004.01515.x.
39. Warriner R, Burrell R. 2005. Infection and the chronic wound: a focus on silver. Adv Skin Wound Care 18(Suppl 1):2-12.